Design Therapeutics, Inc.
DSGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001807120
No open-market purchases or sales by Design Therapeutics, Inc. insiders were filed in the last 90 days; 136 institutions reported holding it in 13F filings for Q2 2026, worth $626.4M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Design Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 98 | 93 | −5 |
| Shares | 34.5M | 34.5M | +70.8K (+0.2%) |
| Value | $133.0M | $116.4M | −$16.6M (−12.5%) |
New holders (6)
Institutions that held Design Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ADAR1 Capital Management, LLC | 42,408 | $142.9K | 0.02% |
| Los Angeles Capital Management LLC | 12,735 | $42.9K | 0.00% |
| UMA Financial Services, Inc. | 268 | $904 | 0.00% |
| Rise Advisors, LLC | 130 | $438 | 0.00% |
| IFP Advisors, Inc | 0 | $155 | 0.00% |
| Point72 (DIFC) Ltd | 20 | $66 | 0.00% |
Sold out (11)
Institutions that held Design Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Wellington Management Group LLP | 141,519 | $546.3K |
| Millennium Management LLC | 87,988 | $339.6K |
| MetLife Investment Management | 18,962 | $73.2K |
| Corebridge Financial, Inc. | 15,383 | $59.4K |
| SG Americas Securities, LLC | 12,980 | $50.0K |
| CoreCap Advisors, LLC | 2,879 | $11.1K |
| California State Teachers Retirement System | 2,275 | $8.78K |
| Coldstream Capital Management Inc | 535 | $2.07K |
| Simplex Trading, LLC | 263 | $1.00K |
| GAMMA Investing LLC | 228 | $880 |
| Principal Securities, Inc. | 74 | $457 |